Whole exome sequencing in relapsed or refractory childhood cancer: case series.

Asian Biomed (Res Rev News)

Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok 10330, Thailand.

Published: August 2024

Background: The prognosis for relapsed or refractory childhood cancer is approximately 20%. Genetic alterations are one of the significant contributing factors to the prognosis of patients.

Objective: To investigate the molecular profile of relapsed or refractory childhood cancers in Thai cases.

Methods: The study design is a descriptive study of patients <18 years old, suspected or diagnosed of relapsed or refractory childhood cancer who underwent whole exome sequencing (WES).

Results: WES was successfully performed in both the tumor and the blood or saliva samples obtained from 4 unrelated patients. Six different variants were identified in the , , , and genes. These alterations were found to be associated with tumor aggressiveness.

Conclusion: This study is the first one to demonstrate genetic alterations by using WES in relapsed or refractory childhood cancer in Thai cases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11414774PMC
http://dx.doi.org/10.2478/abm-2024-0025DOI Listing

Publication Analysis

Top Keywords

relapsed refractory
12
refractory childhood
12
childhood cancer
8
exome sequencing
4
sequencing relapsed
4
cancer case
4
case series
4
series background
4
background prognosis
4
prognosis relapsed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!